Dupilumab significantly reduced the risk of exacerbations compared with placebo in children with moderate to severe asthma, regardless of exacerbation history. Dupilumab was shown to consistently ...
Asthma is a global issue. It's estimated that more than 334 million people around the world have asthma. It's a chronic disease that makes it hard to breathe. Asthma often starts in childhood, but can ...
A viewer asks how to tell when their child’s asthma is flaring. Doctor Lacy Anderson has some tell-tale signs of asthma. An asthma exacerbation can be a scary thing to witness for a parent, and even ...
Asthma is a global issue. It's estimated that more than 334 million people around the world have asthma. It's a chronic disease that makes it hard to breathe. Asthma often starts in childhood, but can ...
In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Children with uncontrolled, moderate to severe asthma ...
Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two ...
—Researchers from Australia conducted a year-round study to investigate the impacts of different pollen types on asthma exacerbations in both children and adults. Population studies in children and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback